Quality Life Services Westmont: Drug Log Failures - PA
The drug was Clonazepam, a controlled substance used to treat anxiety disorders. The resident, identified in inspection records only as Resident 33, had a physician's order for one milligram every eight hours as needed. Staff were supposed to administer the medication, document it in the Medication Administration Record, and note it in the nursing record. That is the chain of accountability that exists specifically because Clonazepam is a narcotic with potential for abuse.
Advertisement
Losing sleep over a loved one's care?
The Derila Ergo memory foam pillow supports your neck in any sleep position. 60-day return policy.
See the Derila PillowThe chain broke. Repeatedly.
The dates when staff signed the drug out of the log: January 7 at 7:07 in the evening. January 12 at 7:05 in the morning. January 14 at 8:20 in the morning. January 29 at 6:30 in the morning and again at 8 in the evening. February 5 at 4 in the morning. February 8 at 9:30 in the morning.
Seven separate occasions across January and February 2025. The Medication Administration Records showed nothing. The nursing notes showed nothing. The clinical record, taken as a whole, showed nothing.
When federal inspectors visited the facility on February 20, 2025, they reviewed the controlled drug logs alongside the clinical records and found the gap. The Nursing Home Administrator, interviewed that afternoon at 3:40, confirmed it directly: there was no documented evidence that Clonazepam was administered to Resident 33 on any of those dates and times.
The administrator did not dispute the finding.
Resident 33 is described in a quarterly assessment from December 23, 2024, as someone who could communicate clearly, understood others, and carried a diagnosis of anxiety. A care plan from October 2024 noted the resident's use of anti-anxiety medications and directed staff to administer them as the physician ordered. The physician's order for Clonazepam was dated December 20, 2024, just days before that quarterly assessment.
What the inspection report cannot answer, and what the documentation gap makes impossible to resolve, is what happened to those pills. There are two possibilities. Either the medication was given to the resident and staff simply failed to document it, which is itself a serious recordkeeping failure for a controlled substance. Or the medication was not given, which means someone signed it out of a controlled drug log and the pills went somewhere else.
The inspection report does not say which scenario occurred. The administrator's confirmation that documentation was absent does not resolve the question. It only confirms that no one can prove, from the records that exist, that Resident 33 ever received those seven doses.
That distinction matters for a specific reason. Controlled drug logs at nursing facilities exist precisely because medications like Clonazepam are narcotics with abuse potential. The log is the facility's mechanism for tracking every pill from the moment it arrives in the building to the moment it reaches a resident. When a staff member signs a dose out of that log, the expectation is that the dose will be documented as administered. The two records are supposed to match. At Quality Life Services Westmont, for this resident, over this six-week period, they did not.
The February 5 entry is worth pausing on. Four in the morning. A staff member signed out Clonazepam for a resident with anxiety at four in the morning, and there is no nursing note, no medication record, no documentation of any kind that the resident received it.
The inspection cited deficiencies under Pennsylvania Department of Health codes governing pharmacy services and nursing services. The violation was categorized as having minimal harm or potential for actual harm, and inspectors noted that few residents were affected. One resident, one medication, one six-week window. Those characterizations are the regulatory language for scope and severity. They do not speak to what Resident 33 experienced, or did not experience, during a period when anti-anxiety medication may or may not have been reaching them as prescribed.
A care plan directing staff to administer medication "as ordered by the physician" is only as useful as the staff who carry it out and document it. For Resident 33, the documentation stopped being useful sometime before January 7.
Quality Life Services Westmont is located at 787 Goucher Street in Johnstown. The inspection was completed February 20, 2025.
Of the 26 residents whose records were reviewed during the inspection, only Resident 33 had this problem identified. That is one way to read the finding. Another way to read it is that a controlled narcotic was signed out of a log seven times without any corresponding record of administration, and the facility's own administrator could not produce documentation to account for the discrepancy.
The inspection report does not describe any corrective action taken before inspectors arrived, or any internal investigation the facility had already begun. It describes what inspectors found when they looked: a controlled drug log with seven entries and a clinical record with none.
Resident 33 had anxiety. They had a physician who believed Clonazepam was appropriate for their care. They had a care plan that told staff to give it to them. Whether they actually received it, on seven separate occasions between January and February of this year, is a question the facility's own records cannot answer.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Quality Life Services - Westmont from 2025-02-20 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: November 16, 2026 · Our methodology
QUALITY LIFE SERVICES - WESTMONT in JOHNSTOWN, PA was cited for violations during a health inspection on February 20, 2025.
The drug was Clonazepam, a controlled substance used to treat anxiety disorders.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.